Home | Contact Us | Careers @ apex | Feedback form | What’s New? | Site Map
Search 

 

The AEROECLIPSE* II BAN is an innovative nebulizer that produces aerosol only on inhalation.

  • Aerosol is only created in response to the patient’s inspiratory maneuver.
  • Provides true patient-on-demand therapy
  • Exceptional Aerosol Delivery
  • Clinical Dose Assurance1
  • Environmental Safety
    • Clinicians and caregivers are exposed to significantly less second hand aerosol which has been linked to airway symptoms.1,2
    • Pandemic Preparedness – In the spirit of the precautionary principle reducing aerosol droplets (potential vectors) into the environment is prudent.3
  • Less Wasted Medication1
    • Occupational Health Perspective
    • Infection Control and Prevention Perspective

AEROECLIPSE* II BAN is manufactured by Trudell Medical, Canada., who are leaders in the field of Respiratory aids.

  1. TMI Aerosol Lab, Data on File. 3.0ml Albuterol Solution 0.83mg/ml, 8 L/min 50psi, tidal volume 0.6L, rate 10bpm, 33% duty cycle as inhalation.
  2. Carnathan B, Martin B, Colice G. Second Hand (S)-Albuterol: RT Exposure Risk Following Racemic Albuterol. Respiratory  Care, October 2001, Vol. 46, No. 10.
  3. Tellier R. Review of Aerosol Transmission of Influenza A Virus. Emerging Infectious Diseases, Vol. 12, No.11, November 2006.

  • Patient is inhaling
  • Negative pressure in the nebulizer pulls the diaphragm down
  • The actuator has moved all the way down sealing around the nozzle cover
  • Aerosol is produced

Conventional Nebulizer-Aerosol
output is constant & independent
of respiratory activit

AEROECLIPSE* II Breath Actuated Nebulizer-Provides true patient-on-
demand therapy

Breath Actuated Nebulizer

Conventional Jet Nebulizer

Lung Deposition

Throat Deposition

Lung Deposition

Throat Deposition

72% 38% 32% 68%

Sangwan S, Hull F, Condos R, Smaldone G.  J Aerosol Med 2001;14(3):421


About the Division
Wound Care
Anesthesia & Airway Management
Urology
Respiratory Care
Cardiac Surgery
General Surgery


FEATURE

BENEFIT

CORE VALUE

Unsurpassed Fine Particle Mass Fraction

- Better drug delivery of <5µm particles to the
  small airways; contributes to greater efficacy

Effective

Exceptional Respirable Dose

- Better drug availability for inhalation à greater   efficacy

Effective

Efficient delivery, unsurpassed emitted dose reduces the number of minutes needed per treatment

- Time saving, less patient monitoring, more   acceptable to users

Effective

Air entrainment through the back of the neb conditions aerosol

- Improved delivery of fine particle mass à
  increased effectiveness

Effective

Visual feedback

- Signals proper actuation

Effective

Virtually no environmental drug loss

- Dose assurance, safer environment, no
  medication waste

Safety (& Effective)

One way exhalation valve

- Eliminates mixing of inspirate and expirate

Safety

Drool guard

- Protects contents from contamination

Safety

Built-in mode selector (BAN or continuous)

  •  >Convenient; don’t need attachment to change    modes
  •  >Suitable for a wider range or patient types and    ages

Versatile

Diaphragm and grid system for true breath actuation

- Actuation sensitivity is the lowest in the industry
  (only 15lpm inspiratory effort to trigger);
  excellent for infants and children

Versatile

Spill proof design

- Can be used in an inclined position up to 45°

Versatile

Tested with the most widely used medications

- Data to back up use with a wide variety of drugs

Versatile

Ergonomic size and shape

- Fits comfortably in the hand

Easy to use

Short throw assembly, quarter turn firmly
attaches top to cup

- Quick and easy to set up

Easy to use

Clarified polypropylene

- Easy to see fill lines and the solution

Easy to use

Latex free

- Non allergenic

Easy to use

Feedback from a healthcare provider…

“Without exception, the staff as well as our patients were very impressed with the modifications implemented with the AEROECLIPSE* II BAN.  Your Research and Development Department and any other involved  department…have my gratitude and respect for making an already superior nebulizer even better.  Our COPD patients especially were amazed at how much easier it was to trigger inspiration and as a result did not feel the same level of fatigue than with the previous BAN.  Some patients who previously required the blue adaptor for continuous use because of the difficulty in actuating the BAN were able to use the BAN II the way it is supposed to be used.  
The other modifications such as the actuator switch were also well received but it was the “ease of actuation” which really got our attention.”

RRT, Clinical Education Coordinator
St. Joseph’s Hospital / Candler Hospital
Savannah, Georgia

Feedback from an End-User

“I was so excited to use your product, the AEROECLIPSE* II, Breath Actuated Nebulizer. I have been asthmatic since birth and this will help reduce my time during nebulizer treatments so that I can get back to the ‘normal’ things in life.  It also opened my airway better and is actually easier to use.” Winter Park, Florida

“Breath-actuated nebulisers (AEROECLIPSE* II BAN) release mechanically…controlled doses of aerosol only during inspiration, or a portion thereof, and theoretically may improve delivery to 100% of the generated aerosol.” Knoch
M, Keller M, Expert Opin.Drug Deliv. (2005) 2 (2):377-390.

Emitted Fine Droplet Mass Considerations

  • The AEROECLIPSE* II BAN provides excellent dosing efficiency
  • Mouthpiece configuration encourages oral breathing, which results in significantly better drug delivery1
  • As per guidelines: Titrate the dose to the lowest dose at which effective control of asthma is maintained

1.Hess D. Nebulizers: Principles and Performance. Respiratory Care, 2000: 45:6: 609-622.
2.British Thoracic Society, British Guideline on the Management of Asthma, Nov. 2005: 4.2.2.

ORDERING INFORMATION

PRODUCT

PACK QUANTITY

PACK DIMENSIONS

AeroEclipse* II Ban  

Case Quantity 50

49 cm x 40 cm x 26 cm  

RespiChamber® VHC * HC for use with MV

Case Quantity 10 

24 cm x 11 cm x 25 cm

RespiChamber® VHC * HC for use with MV

Case Quantity 50 

47 cm x 24 cm x 26 cm

AeroVent® VHC

Case Quantity 50   

44 cm x 35 cm x 17 cm 

RespiChamber with Mouthpiece

Case Quantity 150

61 cm  x 43 cm x 29 cm

RespiChamber with Child Mask  

Case Quantity 120   

61 cm x 43 cm x 33 cm

----------------------------------------------------------------------------------------------------------------------------------------

Inhalation Aids

Respi Chamber

Respi Chamber
with Mask

Aero Elipse* II

About the Division | Wound Care | Anesthesia & Airway Management | Urology
Respiratory Care | Cardiac Surgery | General Surgery


Home | About Us | Branded Formulations | Herbal Products | Marketing | Manufacturing | Research & DevelopmentContact Us | Careers @ apex | Feedback form | What's New? | Site Map
apex laboratories and apex® are registered trademarks of the company